5-hydroxytryptamine receptor

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 29: Line 29:
</StructureSection>
</StructureSection>
-
==3D structures of 5-hydroxytryptamine receptor==
 
-
Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}}
 
-
{{#tree:id=OrganizedByTopic|openlevels=0|
 
-
*5-HT 1B
 
- 
-
**[[4iar]] – hHT1B/cytochrome b562 (mutant) + ergotamine - human<br />
 
-
**[[4iaq]] – hHT1B/cytochrome b562 (mutant) + hydroergotamine <br />
 
-
**[[5v54]] – hHT1B/cytochrome b562 (mutant) + methiothepin <br />
 
- 
-
*5-HT 2B
 
- 
-
**[[4nc3]] – hHT2B/cytochrome b562 (mutant) <br />
 
-
**[[4ib4]] – hHT2B/cytochrome b562 (mutant) + ergotamine <br />
 
-
**[[5tvn]] – hHT2B/cytochrome b562 (mutant) + LSD <br />
 
-
**[[5tud]] – hHT2B/cytochrome b562 (mutant) + antibody <br />
 
- 
-
*5-HT 2C
 
- 
-
**[[6bqg]] – hHT2C/cytochrome b562 (mutant) + ergotamine <br />
 
-
**[[6bqh]] – hHT2C/cytochrome b562 + ritanserin <br />
 
- 
-
*5-HT 3A
 
- 
-
**[[4pir]] – mHT3A + VHH15 - mouse<br />
 
-
**[[6be1]] – mHT3A – Cryo EM<br />
 
-
}}
 
==References==
==References==

Revision as of 09:50, 20 February 2019

Human 5-hydroxytryptamine receptor 1B chimera with E. coli cytochrome B562 complex with ergotamine (PDB code 4iar)

Drag the structure with the mouse to rotate


References

  1. Goodsell D. Serotonin Receptor. RCSB PDB-101 (2013) DOI: 10.2210/rcsb_pdb/mom_2013_8
  2. 2.0 2.1 2.2 2.3 Wang C, Jiang Y, Ma J, Wu H, Wacker D, Katritch V, Han GW, Liu W, Huang XP, Vardy E, McCorvy JD, Gao X, Zhou EZ, Melcher K, Zhang C, Bai F, Yang H, Yang L, Jiang H, Roth BL, Cherezov V, Stevens RC, Xu HE. Structural Basis for Molecular Recognition at Serotonin Receptors. Science. 2013 May 3; 340(6132): 610–614. PMID:3644373 [1]
  3. Wiebke J, Schymura Y, Novoyatleva T, Kojonazarov B, Boehm M, Wietelmann A, Luitel H, Murmann K, Krompiec DR, Tretyn A, Pullamsetti SS, Weissmann N, Seeger W, Ghofrani HA, Schermuly RT. 5-HT2B Receptor Antagonists Inhibit Fibrosis and Protect from RV Heart Failure. Biomed Res Int. 2015; 2015: 438403. PMID:4312574 [2]
  4. Nebigil, Etienne, Schaerlinger, Hickel, Launay, Maroteaux. Developmentally Regulated Serotonin 5-HT2B Receptors. DOI: 10.1016/S0736-5748(01)00022-3
  5. Berumen LC, Rodriguez A, Miledi R, Gracia-Alcocer G. Serotonin Receptors in Hippocampus. ScientificWorldJournal. 2012;2012:823493. Epub 2012 May 2. PMID:3353568 [3]
  6. Millan MJ. Serotonin 5-HT2C receptors as a target for the treatment of depressive and anxious states: focus on novel therapeutic strategies. Therapie. 2005 Sep-Oct;60(5):441-60. PMID:16433010
  7. Ge T, Zhang Z, Lv J, Song Y, Fan J, Liu W, Wang X, Hall FS, Li B, Cui R. The role of 5-HT2c receptor on corticosterone-mediated food intake. J Biochem Mol Toxicol. 2017 Jun;31(6). doi: 10.1002/jbt.21890. Epub 2017 Feb 10. PMID:28186389 doi:http://dx.doi.org/10.1002/jbt.21890
  8. Hassaine G,Cedric D, Luigino G, Romain W, Menno BT, Ruud H, Alexandra G, Henning S, Takashi T, Aline D, Christophe M, Xiao-Dan L, Frederic P, Horst V, Hugues N. X-ray Structure of the Mouse Serotonin 5-HT3 Receptor. Nature 512.7514 (2014): 276-81.DOI:10.1038/nature13552
  9. 9.0 9.1 9.2 Thompson AJ, Lummis SCR. 5-HT3 Receptors. Curr Pharm Des. 2006; 12(28): 3615–3630. PMID:2664614 [4]
  10. Maksay G, Zsolt B, Miklós S. Binding Interactions of Antagonists with 5‐Hydroxytryptamine 3A Receptor Models. Journal of Receptors and Signal Transduction 23.2-3 (2003): 255-70. DOI:10.1081/RRS-120025568
  11. Brunton LL, Lazo JS, Parker KL. (2006). Goddman & Gilman's The Pharmacological Basis of Therapeutics. New York: McGraw-Hill. pp. 1000–3. ISBN 978-0-07-142280-2.
Personal tools